Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | -7.41% | -4.58% | +6.84% |
02:31pm | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.84% | 93.41M | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.06% | 22.25B | |
-13.14% | 22.09B | |
-7.75% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Clearside Biomedical : HC Wainwright Starts Clearside Biomedical at Buy With $10 Price Target